Reuters logo
Roche buys U.S. diagnostics company IQuum in $450 million deal
April 7, 2014 / 5:20 AM / in 4 years

Roche buys U.S. diagnostics company IQuum in $450 million deal

ZURICH, April 7 (Reuters) - Swiss drugmaker Roche has agreed to buy privately-held U.S. diagnostics company IQuum in a deal worth up to $450 million to strengthen its molecular diagnostics business.

The Basel-based firm said it will pay IQuum shareholders $275 million upfront and up to $175 million in contingent product-related milestones.

“With IQuum, we further strengthen our molecular diagnostics offerings with cutting-edge technology and products that serve the point of care segment,” said Roland Diggelmann, head of Roche’s diagnostics division, in a statement on Monday. (Reporting by Caroline Copley; Editing by Christopher Cushing)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below